Methods for producing phycotoxins from natural sources, wherein the phycotoxins have a definite compositional profile are described herein. In one embodiment, the phycotoxins are produced by cyanobacteria. In one embodiment, the phycotoxins are produced by continuously culturing cyanobacteria under
Methods for producing phycotoxins from natural sources, wherein the phycotoxins have a definite compositional profile are described herein. In one embodiment, the phycotoxins are produced by cyanobacteria. In one embodiment, the phycotoxins are produced by continuously culturing cyanobacteria under strictly controlled conditions in order to produce a definite compositional profile. In another embodiment, organic nutrients are added to the culture that allows for higher concentrations of neosaxitoxin and saxitoxin or gonyaulatoxins 2 and 3 per weight of the algae. The phycotoxins are isolated primarily from the bacteria but can also be isolated from the culture medium. In one embodiment, the cyanobacteria produce only neosaxitoxin and saxitoxin in a ratio of about 6:1, 5:1, 4:1, or 3:1. In a preferred embodiment, the amount of saxitoxin is less than 20% by weight of the total amount of neosaxitoxin and saxitoxin produced. In another embodiment, the cyanobacteria produce only GTX2 and GTX 3.
대표청구항▼
1. A method for the continuous production of phycotoxins from cyanobacteria, the method comprising (a) inoculating a culture medium with the cyanobacteria, wherein the cyanobacteria is selected from the group consisting of Cylindrospermopsis raciborskii; Aphanizomenon flos-aquae; Aphanizomenon (APh)
1. A method for the continuous production of phycotoxins from cyanobacteria, the method comprising (a) inoculating a culture medium with the cyanobacteria, wherein the cyanobacteria is selected from the group consisting of Cylindrospermopsis raciborskii; Aphanizomenon flos-aquae; Aphanizomenon (APh) issatschenkoi (usaceb) Proskina-Lavrenco; Aphanizomenon gracile (Lemm) Lemm; Aphanizomenon elenkinii var. Gracile Kashtanova; Anabaena circinalis; Lyngbya wollei; and combinations thereof,wherein the culture medium comprises MgSO4.7H2O, NaNO3, K2HPO4, H3BO3, H2SeO4, biotin, vitamin B12, thiamine HCl, CuSO4.5H2O, ZnSO4.7H2O, CoCl2.6H20, NaMoO4.2H2O, Na2EDTA, FeCl3.6H2O, NaHCO3, and MnCl2.H2O, about 2 to about 3.5 mM arginine, about 1 to about 2.2 mM methionine, and about 0.7 to about 1.3 mM allantoic acid;(b) culturing the cyanobacteria in the culture medium at a temperature from 15 to 30° C. under permanent natural or artificial illumination;(c) collecting a volume of culture medium ranging from 20 to 40% of the total volume every 1 to 3 days and replacing the removed volume with fresh culture medium; and(d) harvesting the cyanobacteria to isolate the phycotoxins. 2. The method of claim 1, wherein the cyanobacteria is Aphanizomenon gracile (Lemm) Lemm. 3. The method of claim 1, wherein the cyanobacteria are cultured in a continuous light cycle. 4. The method of claim 1, wherein the cyanobacteria are cultured at a temperature from about 15° C. to about 25° C. 5. The method of claim 1, wherein the cyanobacteria are cultured at a temperature of about 22±2° C. 6. The method of claim 1, wherein the culture medium has a final arginine concentration of about 2.8 mM. 7. The method of claim 1, wherein the culture medium has a final methionine concentration of about 1.7 mM. 8. The method of claim 1, wherein the culture medium has a final allantoic acid concentration of about 1.0 mM.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (35)
Berde Charles B. (Brookline MA) Langer Robert S. (Newton MA), Biodegradable polymer matrices for sustained delivery of local anesthetic agents.
Berman Elizabeth F. (Cincinnati OH) Buckwalter Brian L. (Yardley PA) Cupps Thomas L. (Oxford OH) Gardner Joseph H. (Cincinnati OH), Compounds and compositions having anti-inflammatory and analgesic activity.
Gardner Joseph H. (Cincinnati OH) Kasting Gerald B. (Wyoming OH) Cupps Thomas L. (Oxford OH) Echler Richard S. (Fairfield OH) Gibson Thomas W. (Cincinnati OH) Shulman Joel I. (Cincinnati OH), Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain.
Gardner Joseph H. (Cincinnati OH) Kasting Gerald B. (Wyoming OH) Cupps Thomas L. (Oxford OH) Echler Richard S. (Fairfield OH) Gibson Thomas W. (Cincinnati OH) Shulman Joel I. (Cincinnati OH), Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain.
Patel Dinesh C. (Murray UT) Chang Yunik (Lakewood NJ), Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols.
Sanders Harold F. (Palo Alto CA) Cheng Yu-Ling (Cupertino CA) Enscore David J. (Saratoga CA) Libicki Shari B. (Palo Alto CA), Transdermal drug composition with dual permeation enhancers.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.